Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

Status:	Recruiting
Conditions:	Other Indications, Blood Cancer
Therapuetic Areas:	Oncology, Other
Healthy:	No
Age Range:	18 - 75
Updated:	1/17/2019
Start Date:	February 2016
End Date:	February 2020
Contact:	Boglarka Gyurkocza, MD
Phone:	212-639-2860

Observational Study to Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

The investigators are doing this research study to assess the percentage of patients
receiving stem cell transplantation for the type of blood cancer you have. They want to know
how many patients get a transplant and why some patients do get a transplant while others do
not. Also they want to explore why some patients elect not to undergo stem cell
transplantation, when it is recommended by their physicians.

Inclusion Criteria:

- Patients with newly diagnosed or relapsed acute leukemia. Patients undergoing
reinduction due to primary induction failure are also eligible.

- 18 years of age or older and 75 years of age or younger, admitted for treatment on the
Adult Leukemia Service.

Exclusion Criteria:

- Patients with relapsed acute leukemia post-allogeneic transplant

We found this trial at

sites

Memorial Sloan Kettering Cancer Center

1275 York Ave
New York, New York 10021

(212) 639-2000